These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2697855)

  • 21. Multidrug resistance in lung allograft recipients: possible correlation with the development of acute and chronic rejection.
    Yousem SA; Sartori D; Sonmez-Alpan E
    J Heart Lung Transplant; 1993; 12(1 Pt 1):20-6. PubMed ID: 8095160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive coronary artery vasculopathy after combined heart-lung transplantation.
    Hayes D; Baker PB; Astor TL; Preston TJ; Kirkby S; Galantowicz M; Hoffman TM
    Congenit Heart Dis; 2013; 8(3):E88-91. PubMed ID: 22676698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
    Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
    J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy.
    Hutter JA; Stewart S; Higenbottam T; Scott JP; Wallwork J
    J Heart Transplant; 1988; 7(6):440-4. PubMed ID: 3145335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
    Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
    J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
    Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
    Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of chronic lung transplant rejection by transbronchial biopsy.
    Cagle PT; Brown RW; Frost A; Kellar C; Yousem SA
    Mod Pathol; 1995 Feb; 8(2):137-42. PubMed ID: 7777473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lung rejection in pulmonary and cardiopulmonary transplantation].
    Groussard O
    Ann Pathol; 1993; 13(1):8-16. PubMed ID: 8489655
    [No Abstract]   [Full Text] [Related]  

  • 29. Graft vessel disease and obliterative bronchiolitis after heart/lung transplantation in children.
    Radley-Smith RC; Burke M; Pomerance A; Yacoub MH
    Transplant Proc; 1995 Jun; 27(3):2017-8. PubMed ID: 7792871
    [No Abstract]   [Full Text] [Related]  

  • 30. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchiolitis with airflow obstruction.
    Epler GR
    Curr Opin Pulm Med; 1995 Mar; 1(2):109-18. PubMed ID: 15786600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lung transplantation. Indications, preoperative evaluation and postoperative treatment].
    Svendsen UG; Aggestrup S; Aldershvile J; Arendrup HC; Mortensen SA; Thiis JJ; Petterson G
    Ugeskr Laeger; 1994 Dec; 156(50):7510-5. PubMed ID: 7839514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease.
    Epler GR
    Clin Chest Med; 1988 Dec; 9(4):551-6. PubMed ID: 3069287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological grading of acute lung rejection on transbronchial biopsy helps predict long-term outcome of heart-lung transplants.
    Clelland CA; Higenbottam TW; Otulana BA; Stewart S; Scott JP; McGoldrick J; Wallwork J
    Transplant Proc; 1990 Aug; 22(4):1480. PubMed ID: 2389373
    [No Abstract]   [Full Text] [Related]  

  • 39. Pediatric lung and heart-lung transplantation.
    Bolman RM
    Transplant Proc; 1994 Feb; 26(1):211-3. PubMed ID: 8108946
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic consequences of transplantation.
    Keenan RJ; Zeevi A
    Chest Surg Clin N Am; 1995 Feb; 5(1):107-20. PubMed ID: 7743142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.